ALVO.IC Alvotech

P/E --
Forward P/E --
Price/Sales 458.81915
Beta 0.205
Div Yield 0.0%
Market Cap --

Company Analysis

Latest News

🟒 Alvotech is trading 10.8% up today on a technical rebound following recent weakness

🟒 Alvotech is trading 10.8% up today on a technical rebound following recent weakness

Alvotech is trading 10.8% up at ISK 431 on a technical rebound following several sessions of weakness and elevated investor concerns regarding earnings and...

🟒 Alvotech is trading 5.7% up today, rebounding from recent weakness

Alvotech is trading at ISK 411 (5.7% gain), rebounding from recent weakness in the stock. β€’ The move comes despite a lack of fresh company-specific...

πŸ”΄ Alvotech is trading 8.5% down today amid broader market caution and prior earnings weakness

Alvotech is trading 8.47% down at ISK 400.00 amid broader risk-off sentiment in biotech and high-volatility names following a weak prior session. β€’ No fresh...

πŸ”΄ Alvotech is trading 4.19% down in pre-market

ALVO.IC is trading at $412.00, down 4.19% in pre-market.

πŸ”΄ ALVO.IC is trading 3% down today, extending a multi-session downtrend

ALVO.IC is trading 3% down today at $424, extending a multi-session downtrend fueled by mixed sentiment surrounding the company's fundamentals. β€’ Investor...

Alvotech Secures $75 Million Loan, Accelerating Global Biosimilar Product Launches

Alvotech Secures $75 Million Loan, Accelerating Global Biosimilar Product Launches

Alvotech amended its credit agreement to add a $75 million term loan facility. GoldenTree Asset Management and existing lenders led the financing. The new...

🟒 ALVO.IC extends move to 5.4% up

ALVO.IC is trading at $486.00, up 5.4% versus the comparison close of $461.00 during regular trading. This is a price-movement alert; no separate...

🟒 ALVO.IC is trading 4.6% up today on renewed biotech interest

ALVO.IC is trading 4.6% up today at $482.00, extending Monday’s gains as the move appears driven by renewed biotech interest and general market risk...